Cochlear Limited Cochlear Limited

Cochlear Limited

COH

Rank in Stocks #2851
Globally, Cochlear Limited specializes in the development and provision of... Globally, Cochlear Limited specializes in the development and provision of implantable auditory solutions for both children and adults. The company's diverse offerings include advanced cochlear implant systems, upgrades for sound processors, bone conduction devices, and a wide array of accessories and other related items. Established in 1981, its global operations are directed from its headquarters in Sydney, Australia.
Share Price
$99.82
Market Cap
$6.53B
Change (1 day)
1.03%
Change (1 year)
-46.67%
Country
AU
Trade Cochlear Limited (COH)

Category

Healthcare
Revenue for Cochlear Limited (COH)
Revenue in Jun 2026 TTM: $1.65B
According to Cochlear Limited latest financial reports the company's current revenue (TTM) is $1.65B. In 2024 the company made a revenue of $1.49B an increase over the revenue in the year 2023 that was $1.29B. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Cochlear Limited from 2000 to 2026
Revenue at the end of each year
Year Revenue Change
2026 (TTM) $1.65B 6.75%
2025 $1.54B 3.33%
2024 $1.49B 15.71%
2023 $1.29B 13.96%
2022 $1.13B 1.09%
2021 $1.12B 20.00%
2020 $933.09M -6.87%
2019 $1.00B -0.79%
2018 $1.01B 4.61%
2017 $965.50M 14.64%
2016 $842.22M 18.18%
2015 $712.67M -6.14%
2014 $759.25M 10.38%
2013 $687.85M -13.60%
2012 $796.17M -8.29%
2011 $868.14M 39.50%
2010 $622.30M 10.71%
2009 $562.10M -2.62%
2008 $577.21M 21.52%
2007 $475.00M 41.42%
2006 $335.87M 28.02%
2005 $262.36M 33.59%
2004 $196.38M 1.49%
2003 $193.50M 34.70%
2002 $143.65M 28.37%
2001 $111.91M 0.00%
2000 0.00 0.00%
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
$46.59B 2,729.11%
US
$35.48B 2,054.95%
IE
$25.84B 1,469.09%
US
$21.00B 1,175.09%
US
- -
DE